Biotech · Private company · Baltimore, MD, US
Isoprene Pharmaceuticals, Inc.
Track this companyFree. Adds Isoprene Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of VNPP433-3Beta as Novel Therapeutic for All Stages of Prostrate CancerFiscal year 2026 · $1MNIH RePORTER 5R44CA291285-02 · fetched Nov 12, 2026
- Development of VNPP433-3Beta as Novel Therapeutic for All Stages of Prostrate CancerFiscal year 2025 · $1MNIH RePORTER 1R44CA291285-01A1 · fetched Nov 12, 2026